NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...
NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial of a biotech drug for treating cancer, the two companies said.
